The RasGRP3 expression increases in SLE B lymphocytes and PBMCs, which results in enhanced activation of B lymphocytes through ERK1/2 and AKT signaling pathways and the overproduction of inflammatory interleukins such as TNF-α and IL-6 (122). The gene discussed is RASGRP3; the disease is systemic lupus erythematosus.